A. Lucenti

870 total citations
15 papers, 677 citations indexed

About

A. Lucenti is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, A. Lucenti has authored 15 papers receiving a total of 677 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Surgery and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in A. Lucenti's work include Cancer Treatment and Pharmacology (2 papers), Ovarian cancer diagnosis and treatment (2 papers) and HER2/EGFR in Cancer Research (2 papers). A. Lucenti is often cited by papers focused on Cancer Treatment and Pharmacology (2 papers), Ovarian cancer diagnosis and treatment (2 papers) and HER2/EGFR in Cancer Research (2 papers). A. Lucenti collaborates with scholars based in Italy, Ukraine and Germany. A. Lucenti's co-authors include Enzo Galligioni, Orazio Caffo, Maurizio Amichetti, F. Valduga, Antonella Ferro, Mattia Barbareschi, D Aldovini, Claudio Doglioni, Patrick Maisonneuve and Silvio Veronese and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Oncology.

In The Last Decade

A. Lucenti

14 papers receiving 650 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Lucenti Italy	10	306	193	193	148	131	15	677
Oskar Franklin Sweden	11	268 0.9×	164 0.8×	59 0.3×	80 0.5×	54 0.4×	32	497
Janet Yoon United States	9	133 0.4×	118 0.6×	64 0.3×	40 0.3×	39 0.3×	23	381
Hideaki Yahata Japan	15	190 0.6×	268 1.4×	77 0.4×	144 1.0×	25 0.2×	70	1.1k
João Pinto-de-Sousa Portugal	14	239 0.8×	369 1.9×	218 1.1×	313 2.1×	37 0.3×	51	784
Steven S. Chang United States	17	292 1.0×	681 3.5×	149 0.8×	175 1.2×	19 0.1×	46	1.2k
Emma Dorris Ireland	10	170 0.6×	272 1.4×	85 0.4×	49 0.3×	31 0.2×	23	595
M. Bauer Germany	12	130 0.4×	262 1.4×	86 0.4×	50 0.3×	37 0.3×	31	581
Enrico Breda Italy	16	273 0.9×	134 0.7×	110 0.6×	370 2.5×	9 0.1×	39	996
Rebecca Marcus United States	11	230 0.8×	223 1.2×	134 0.7×	221 1.5×	49 0.4×	27	677
Jacob McGee Canada	12	174 0.6×	131 0.7×	44 0.2×	166 1.1×	37 0.3×	35	575

Countries citing papers authored by A. Lucenti

Since Specialization

Citations

This map shows the geographic impact of A. Lucenti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Lucenti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Lucenti more than expected).

Fields of papers citing papers by A. Lucenti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Lucenti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Lucenti. The network helps show where A. Lucenti may publish in the future.

Co-authorship network of co-authors of A. Lucenti

This figure shows the co-authorship network connecting the top 25 collaborators of A. Lucenti. A scholar is included among the top collaborators of A. Lucenti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Lucenti. A. Lucenti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Reni, Michele, Guido Giordano, Marina Macchini, et al.. (2024). Exploring external validity of chemotherapy for pancreatic ductal adenocarcinoma in real life. Digestive and Liver Disease. 57(1). 104–110.

Muscaritoli, Maurizio, Alessandra Modena, Paolo Marchetti, et al.. (2023). The Impact of NUTRItional Status at First Medical Oncology Visit on Clinical Outcomes: The NUTRIONCO Study. Cancers. 15(12). 3206–3206. 9 indexed citations

Adamo, Vincenzo, Giuseppina Rosaria Rita Ricciardi, Dario Giuffrida, et al.. (2017). Multicenter study of the evaluation of eribulin (E) use in Sicily in metastatic breast cancer (MBC): A prospective registry (VESPRY trial).. Journal of Clinical Oncology. 35(15_suppl). e12565–e12565. 1 indexed citations

Crivellari, Diana, Davide Lombardi, Giuseppe Corona, et al.. (2006). Innovative schedule of oral idarubicin in elderly patients with metastatic breast cancer: comprehensive results of a phase II multi-institutional study with pharmacokinetic drug monitoring. Annals of Oncology. 17(5). 807–812. 16 indexed citations

Sorio, Roberto, Germana Tognon, Angela Gambino, et al.. (2004). A Phase II Study of Liposomal Doxorubicin in Recurrent Epithelial Ovarian Carcinoma. Tumori Journal. 90(6). 556–561. 11 indexed citations

Barbareschi, Mattia, Patrick Maisonneuve, D Aldovini, et al.. (2003). High syndecan‐1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis. Cancer. 98(3). 474–483. 197 indexed citations

Caffo, Orazio, Maurizio Amichetti, Antonella Ferro, et al.. (2003). Pain and Quality of Life after Surgery for Breast Cancer. Breast Cancer Research and Treatment. 80(1). 39–48. 146 indexed citations

Barbareschi, Mattia, Roberto Togni, D Aldovini, et al.. (2003). [Tissue microarrays in oncology].. PubMed. 95(5). 265–6. 2 indexed citations

Caffo, Orazio, Maurizio Amichetti, Daniela Bernardi, et al.. (2000). Concurrent adjuvant chemotherapy and immediate breast reconstruction with skin expanders after mastectomy for breast cancer. Breast Cancer Research and Treatment. 60(3). 267–275. 39 indexed citations

10.

Gatzemeier, U., Joachim von Pawel, Maya Gottfried, et al.. (2000). Phase III Comparative Study of High-Dose Cisplatin Versus a Combination of Paclitaxel and Cisplatin in Patients With Advanced Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 18(19). 3390–3399. 177 indexed citations

11.

Simonelli, Cecilia, Stefania Zanussi, Manola Comar, et al.. (1999). Concomitant Therapy With Subcutaneous Interleukin-2 and Zidovudine Plus Didanosine in Patients With Early Stage HIV Infection. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 20(1). 20–27. 31 indexed citations

12.

Boccardo, Francesco, A. Rubagotti, Luciano Canobbio, et al.. (1998). Interleukin-2, Interferon-α and Interleukin-2 plus Interferon-α in Renal Cell Carcinoma. A Randomized Phase Ii Trial. Tumori Journal. 84(5). 534–539. 19 indexed citations

13.

Vaccher, Emanuela, Michele Spina, Renato Talamini, et al.. (1998). CONCOMITANT CHOP CHEMOTHERAPY (CT) AND HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART) IN PATIENTS (PTS) WITH HIV-RELATED NON-HODGKIN'S LYMPHOMA (HIV-NHL).. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 17(4). A30–A30. 10 indexed citations

14.

Cacciaguerra, S., A. Lucenti, Simone Gangarossa, et al.. (1996). Hepatobiliary cystadenoma with hyaline stroma. Pediatric Surgery International. 11(5-6). 380–383. 3 indexed citations

15.

Mazzone, D, Gaetano Magro, A. Lucenti, & Sebastiano Grasso. (1995). Report of a case of congenital glioblastoma multiforme: an immunohistochemical study. Child s Nervous System. 11(5). 311–313. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact